KHAN , R.; MASOOD , A.; KHAN , S.; MASOOD , A.; ABDULMANAN, .; ZULFIQAR , A. DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS. Biological and Clinical Sciences Research Journal, [S. l.], v. 2024, n. 1, p. 654, 2024. DOI: 10.54112/bcsrj.v2024i1.654. Disponível em: https://bcsrj.com/ojs/index.php/bcsrj/article/view/654. Acesso em: 13 may. 2024.